7.1 Patient-Centred Counselling

7.1 Patient-Centred Counselling

Quick Answer: Effective counselling is a structured conversation, not a monologue at the counter. Cover why the medicine is used, how to take it, what to expect (benefit and common effects), which side effects need action, and how to store it. Adapt language, cultural context, and literacy; protect privacy; teach devices (inhalers, insulin pens) with demonstration; prioritise differently for new versus refill supplies; and use Consumer Medicines Information (CMI) as support, not a substitute for dialogue.

National Competency Standard 3.2.5 expects pharmacists to provide medication information and counselling that enables safe, effective use — including in acute and primary care settings. Counselling is the final safety layer after prescription evaluation, clinical appropriateness, and labelling (Chapter 6).

Why counselling is a core clinical act

A correctly dispensed pack can still cause harm if the patient:

• Takes the wrong dose or at the wrong time
• Misses critical interactions (e.g. alcohol with metronidazole)
• Continues a medicine that should stop when red-flag symptoms appear
• Uses an inhaler or pen with technique that delivers little active drug
• Stores insulin or vaccines incorrectly
• Never understands the purpose, so adherence collapses within days

Intern Written stems often test whether you can choose counselling that is complete, prioritised, and patient-centred under time pressure — not whether you can recite every line of a product information document.

The five-part counselling structure

Use a repeatable scaffold. The Australian Pharmaceutical Formulary and Handbook (APF) counselling frameworks and cautionary advisory labels support this structure; the AMH supplies clinical facts you may need to tailor messages.

Purpose (therapeutic goal)

Patients adhere better when they understand the goal: cure infection, lower blood pressure long-term, prevent clots, relieve pain short-term. Distinguish symptom relief from disease-modifying or preventive therapy. For antibiotics, state that finishing the course as prescribed matters even if symptoms improve early (unless a clinician has advised otherwise).

How to take (regimen fidelity)

Be concrete:

• Exact dose and timing (morning/night, with meals, empty stomach)
• Duration and whether to stop early
• What to do if a dose is missed (generally: take when remembered unless near next dose — verify for that medicine)
• Administration specifics: do not crush modified-release tablets; shake suspensions; use the provided measuring device, not a kitchen spoon
• Spacing from interacting products (e.g. calcium or iron reducing absorption of some antibacterials — separate dosing)

What to expect

Set realistic timelines (antibiotics, antidepressants, inhaled preventers) so patients do not abandon therapy or double-dose in frustration. Normalise common, self-limiting effects where appropriate, while never dismissing patient concern.

Side effects that need action

Prioritise actionable safety messages over encyclopaedic lists:

• Hypersensitivity and anaphylaxis features
• Bleeding on anticoagulants
• Severe diarrhoea with antibiotics (possible Clostridioides difficile concern)
• Signs of hypoglycaemia with insulin or sulfonylureas
• Respiratory deterioration, chest pain, neurological deficits
• Medicine-specific boxed or high-priority warnings from AMH monographs

Tell patients what to do: stop the medicine if appropriate, seek GP/pharmacist review, present to emergency, or call 000.

Storage

Cover temperature, light, moisture, fridge items (insulin, some biologics, reconstituted antibiotics), in-use expiry, and safe storage away from children and pets. For travel, plan cooler bags and security rules without improvising illegal export of controlled drugs.

Cultural and literacy adaptations

Patient-centred counselling is not one script for every adult.

Literacy and health literacy

• Prefer plain Australian English; avoid unexplained jargon ("bid", "PRN", "renal clearance")
• Chunk information; lead with the two or three actions that prevent harm today
• Use teach-back (Section 7.2) rather than "Do you understand?"
• Offer written anchors: labelled directions, CMI, simple pictograms, dosette explanations
• Check vision, hearing, and language preference; use professional interpreters when needed — family translation is a last resort for complex or sensitive content

Cultural responsiveness

• Respect beliefs about medicines, traditional therapies, fasting (e.g. Ramadan timing of doses), gender preferences for discussion, and decision-making involving family or community
• Avoid assumptions based on appearance or surname
• For Aboriginal and Torres Strait Islander peoples, apply culturally safe communication: respectful pace, plain language, awareness of shame and power dynamics, and linkage to Aboriginal Community Controlled Health Services when appropriate
• Explore complementary medicines and over-the-counter products non-judgmentally — they may interact or replace prescribed therapy

Capacity and carers

When cognitive impairment, acute illness, or language barriers limit understanding, counsel the responsible carer with consent, while still including the patient as much as possible. Confirm who will administer doses at home.

Privacy at the counter and in the consult room

Counselling often involves diagnoses, sexual health, mental health, substance use, or pregnancy. Professional and privacy obligations require reasonable steps to protect confidentiality:

• Offer a private counselling area or consult room for sensitive or complex medicines
• Lower voice at the open counter; avoid calling out medicine names and conditions loudly
• Confirm identity before discussing medicines
• Obtain consent before discussing details with family, friends, or third parties collecting medicines
• Do not display computer screens with clinical data to bystanders

If privacy cannot be assured and the content is sensitive, relocate the conversation or schedule a quieter time rather than forcing full disclosure in a crowded queue.

Device counselling: inhalers and insulin pens (high-level)

Devices fail most often because of technique, not product quality.

Inhalers (asthma/COPD themes)

Key counselling themes (technique details vary by device class — MDI, DPI, soft mist):

1. Prepare — remove cap, check dose counter, shake if required for that device
2. Load/actuate correctly — prime new MDIs when required; load DPI dose without tipping or exhaling into the device
3. Exhale gently away from the device, seal lips, inhale with the correct flow (slow and deep for many MDIs; forceful for many DPIs)
4. Coordinate actuation with inhalation for MDIs; consider a spacer for MDIs, especially for children or those with poor coordination
5. Breath-hold when recommended, then exhale
6. Rinse mouth after inhaled corticosteroids to reduce thrush and hoarseness
7. Cleaning and replacement — know when the device is empty; do not immerse all devices in water

Demonstrate with a placebo trainer when available, then invite the patient to show you. Technique drifts over time — recheck at refills for preventers and relievers.

Insulin pens (high-level)

1. Confirm insulin type (rapid-, short-, intermediate-, long-acting, or mix) and prescribed dose in units
2. Attach a new needle; prime according to product instructions until a drop appears
3. Dial the correct dose; inject into recommended subcutaneous sites with site rotation
4. Count hold-time after injection before withdrawing the needle
5. Safe sharps disposal; never share pens or needles
6. Storage: unopened in fridge; in-use pen usually at room temperature per product advice; never freeze; protect from heat
7. Hypoglycaemia recognition and response; when to seek urgent care

Do not invent brand-specific steps under exam pressure — apply AMH/APF and product principles: correct insulin, correct units, prime, inject subcutaneously, store safely, manage hypos.

New versus refill counselling priorities

New supply: invest time in safe initiation. Refill: find problems early — "How are you getting on with this?" beats "Any questions?" alone.

Using Consumer Medicines Information (CMI) appropriately

CMI is a TGA-aligned consumer leaflet for many registered medicines.

Do:

• Offer CMI, especially for new medicines or complex regimens
• Point to sections that match your verbal priorities (how to take, side effects needing action)
• Use CMI to reinforce, not replace, conversation
• Ensure the patient can read it or has a carer who can

Do not:

• Hand a CMI silently and consider counselling complete
• Assume every medicine has an up-to-date CMI always on hand — still counsel from professional knowledge and APF/AMH principles
• Overwhelm with every listed adverse effect without prioritising
• Use CMI as a defence for skipping teach-back on critical safety points

Link CMI to cautionary advisory labels on the pack so verbal, label, and written messages align.

Putting it together: a practical workflow

1. Confirm identity and privacy needs
2. Open with purpose in plain language
3. Walk through how to take, using the labelled directions as the anchor
4. Cover expectations and action-needed side effects
5. Address storage and practical barriers (shift work, swallowing, cost, literacy)
6. Demonstrate devices; invite return demonstration
7. Offer CMI and highlight key sections
8. Check understanding (teach-back — Section 7.2)
9. Invite questions; document significant education when clinically important

Exam mindset

Intern Written items may show a busy counter, a carer collecting, a first inhaler, a new anticoagulant, or a patient who "already knows" their long-term tablet. Choose the option that delivers structured, prioritised, private, adaptive counselling with device skill when relevant — not the option that only prints a label or only provides a leaflet.